• I-SPY Phase 1

    A Phase Ib clinical trial designed to decrease the amount of time required to collect drug safety data for entry into I-SPY 2.

  • I-SPY 2

    A Phase II neoadjuvant clinical trial designed to decrease the amount of time required to collect drug efficacy data.

  • I-SPY 3

    An international confirmatory Phase III neoadjuvant clinical trial for successful I-SPY 2 agents.

  • I-SPY 2 PATIENT SITE

    Information for interested participants in the I-SPY 2 Clinical Trial.

Two I-SPY 2 Efficacy Papers released in the New England Journal of Medicine

July 6th, 2016
read more

June 2016: I-SPY 2 Enrolled its 1000th Patient!

    Thank you to the all the remarkable patients for their participation in this trial, and thank you to all of the investigators, research staff and advocates for all of their support.

THE I-SPY TRIALS ARE AN UNPRECEDENTED AND STREAMLINED APPROACH TO CLINICAL TRIAL DESIGN
Using breast cancer treatment as a model - the I-SPY TRIALs aim to significantly reduce the cost, time, and number of patients required to bring new drugs to patients who need them.